$CSAI

Cloudastructure Schedules Q1 2026 Earnings Call

Cloudastructure, Inc. (Nasdaq: CSAI) scheduled its Q1 2026 earnings call for July 17, 2026 at 12:00 p.m. ET to discuss results for the quarter ended March 31, 2026 and provide a business update. The company said its Q1 filing was delayed due to a technical accounting review of convertible preferred stock classification, later resolved via amended Series 2 terms.

Original reporting
Published Jul 16, 2026, 12:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 12:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cloudastructure Schedules Q1 2026 Earnings Call — source image
Decision brief

The 30-second read

$CSAINeutralMed
01

Why it matters

The company resolved the Series 2 variable conversion price feature and exchanged 1,170 shares for an unsecured promissory note, and it plans a revised non-cash accounting presentation for both series in the upcoming Q1 filing.

02

Market read

Traders should be positioned for earnings-day volatility on July 17, with attention to whether the accounting-related delay and revised presentation affect investor confidence or guidance expectations.

03

What to watch

If the market interprets the convertible preferred stock amendments as a sign of prior reporting uncertainty, valuation and risk premia could reprice even without cash impact.

Relevance 5/10Novelty 5/10Timing: Ahead of the July 17 pre-market Q1 2026 earnings release and business update.

Background

Cloudastructure delayed its Q1 2026 filing pending review of a technical accounting matter about balance sheet classification for Series 1 and Series 2 convertible preferred stock.

Company-level read

Ticker impact

$CSAINeutralMedium confidence
Context

Cloudastructure (CSAI) scheduled its Q1 2026 earnings call for July 17 and said its filing was delayed over convertible preferred stock accounting classification.

Expected impact

Moderate two-sided volatility around the July 17 pre-market print, driven by whether investors view the accounting presentation change as immaterial or a signal of broader reporting complexity.

Evidence & confidence

The article provides a concrete catalyst date (earnings before market open) and a specific accounting-related delay/resolution, but it does not include Q1 results, guidance, or cash impact.

Market effects

Limited. The news is company-specific to cloud security and remote guarding, with no broader sector datapoints.

Limited. No regional macro or policy drivers are cited.

Limited. No international deal, regulator, or supply-chain event is described.

Counterpoint

Investors may discount the accounting presentation change as non-cash and focus primarily on revenue growth and customer traction, making the call a routine calendar event.

Key entities

  • Cloudastructure, Inc.

    Nasdaq-listed cloud-native AI surveillance and remote guarding provider scheduling its Q1 2026 earnings call.

  • Series 2 Convertible Preferred Stock

    Amended to eliminate variable conversion price feature; 1,170 shares exchanged for an unsecured promissory note.

  • Series 1 Convertible Preferred Stock

    Balance sheet classification review referenced as part of the delayed Q1 2026 filing.

Related articles

$CSAIMed

CLOUDASTRUCTURE, INC. (CSAI): Results of Operations and Financial Condition

CLOUDASTRUCTURE, INC. (CSAI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cloud_ex9901.htm PRESS RELEASE DATED AUGUST 17, 2026 Exhibit 99.1 Cloudastructure Reports 164% Year-Over-Year Growth in Subscription Revenue for the Second Quarter 2026 Revenue Mix Continued Shifting Toward Recurring, Higher-Margin Services as Gross Profit Increased 53%

$LONAMed

LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances

LeonaBio (NASDAQ:LONA) reported a Q2 loss of $0.80 per share, smaller than analysts’ $1.12 forecast. Net loss rose to $19.0 million from $7.0 million a year earlier. Phase 3 ELAINE-3 enrollment nears 600 target, with 495 patients enrolled and topline results expected in H2 2027. Cash fell to $51.1 million from $88.3 million.

$JSPRMed

Jasper Therapeutics beats Q2 expectations but shares fall after results

Jasper Therapeutics (NASDAQ:JSPR) reported Q2 2026 adjusted loss of $0.10 per share, better than the $0.28 consensus, and a net loss of $2.8 million. Shares fell 4.24% pre-market. In July, Jasper completed an all-stock acquisition of Kira Pharmaceuticals and a $132 million private placement, extending its funding runway into 2H 2028. Pipeline updates include KP-104 Phase 2 interim data in Q4 2026 and briquilimab and KP-701 milestones in early 2027.

$PPSIMed

PIONEER POWER SOLUTIONS, INC. (PPSI): Results of Operations and Financial Condition

PIONEER POWER SOLUTIONS, INC. (PPSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Pioneer Power Announces Financial Results for Second Quarter 2026 and Provides a Business Update ● Backlog Grew 32% Sequentially to $18.4 Million ● Projecting Revenue of Approximately $15 Million in Second Half of 2026, Representing More

$BDCOMed

BLUE DOLPHIN ENERGY CO (BDCO): Results of Operations and Financial Condition

BLUE DOLPHIN ENERGY CO (BDCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_967513.htm EXHIBIT 99.1 BDCO EARNINGS RLS DATED AUGUST 17, 2026 ex_967513.htm Exhibit 99.1 PRESS RELEASE FOR IMMEDIATE RELEASE BLUE DOLPHIN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS ● Total gross profit of $25.1 million and $45.7 million for the three and six mon